200 related articles for article (PubMed ID: 31429640)
1. Treatment of Medication-Related Osteonecrosis of the Jaw Around the Dental Implant With a Once-Weekly Teriparatide: A Case Report and Literature Review.
Kim JY; Park JH; Jung HD; Jung YS
J Oral Implantol; 2019 Oct; 45(5):403-407. PubMed ID: 31429640
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Osteonecrosis of the Jaw.
Yamachika E; Matsubara M; Ikeda A; Matsumura T; Moritani N; Iida S
J Craniofac Surg; 2015 Oct; 26(7):e575-7. PubMed ID: 26468825
[TBL] [Abstract][Full Text] [Related]
3. A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.
Ohbayashi Y; Iwasaki A; Nakai F; Mashiba T; Miyake M
Osteoporos Int; 2020 Mar; 31(3):577-585. PubMed ID: 31768589
[TBL] [Abstract][Full Text] [Related]
4. Teriparatide for the Treatment of Medication-Related Osteonecrosis of the Jaw.
Chopra K; Malhan N
Am J Ther; 2020 Jun; 28(4):e469-e477. PubMed ID: 32618592
[TBL] [Abstract][Full Text] [Related]
5. Medication-Related Osteonecrosis of the Jaw Subsequent to Peri-Implantitis: A Case Report and Literature Review.
Seki K; Namaki S; Kamimoto A; Hagiwara Y
J Oral Implantol; 2021 Dec; 47(6):502-510. PubMed ID: 33270837
[TBL] [Abstract][Full Text] [Related]
6. Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings.
Kakehashi H; Ando T; Minamizato T; Nakatani Y; Kawasaki T; Ikeda H; Kuroshima S; Kawakami A; Asahina I
Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1558-64. PubMed ID: 26304604
[TBL] [Abstract][Full Text] [Related]
7. [The recombinant human parathyroid hormone, teriparatide as an alternative remedy for the medication-related osteonecrosis of the jaw].
Gera I; Szücs N
Orv Hetil; 2023 Sep; 164(36):1406-1415. PubMed ID: 37695713
[TBL] [Abstract][Full Text] [Related]
8. Short-Term Teriparatide and Recombinant Human Bone Morphogenetic Protein-2 for Regenerative Approach to Medication-Related Osteonecrosis of the Jaw: A Preliminary Study.
Jung J; Yoo HY; Kim GT; Lee JW; Lee YA; Kim DY; Kwon YD
J Bone Miner Res; 2017 Dec; 32(12):2445-2452. PubMed ID: 28815779
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive recombinant human parathyroid hormone agents for the treatment of medication-related osteonecrosis of the jaw: a report of three cases.
Choi SY; Yoon D; Kim KM; Kim SJ; Kim HY; Kim JW; Park JH
J Korean Assoc Oral Maxillofac Surg; 2024 Apr; 50(2):103-109. PubMed ID: 38693133
[TBL] [Abstract][Full Text] [Related]
10. Effective ancillary role and long-term course of daily or weekly teriparatide treatment on refractory medication-related osteonecrosis of the jaw: a clinical case series.
Yoshiga D; Yoshioka I; Habu M; Sasaguri M; Tominaga K
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):604-609. PubMed ID: 34996629
[TBL] [Abstract][Full Text] [Related]
11. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.
Dos Santos Ferreira L; Abreu LG; Calderipe CB; Martins MD; Schuch LF; Vasconcelos ACU
Osteoporos Int; 2021 Dec; 32(12):2449-2459. PubMed ID: 34331067
[TBL] [Abstract][Full Text] [Related]
12. Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw associated with dental implants.
Doh RM; Park HJ; Rhee Y; Kim HS; Huh J; Park W
Implant Dent; 2015 Apr; 24(2):222-6. PubMed ID: 25734949
[TBL] [Abstract][Full Text] [Related]
13. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
[TBL] [Abstract][Full Text] [Related]
14. Successful New Dental Implant Installation in a Healed Site of Medication-Related Osteonecrosis of the Jaw: A Case Report.
Lee JY; Park JU; Lee SY
J Oral Implantol; 2023 Apr; 49(2):117-123. PubMed ID: 37025054
[TBL] [Abstract][Full Text] [Related]
15. Is medication related osteonecrosis of the jaw around implants a rare entity? A case series with a focus on etiopathophysiology.
Massaad J; Magremanne M
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e743-e748. PubMed ID: 34922047
[TBL] [Abstract][Full Text] [Related]
16. Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report.
Zushi Y; Takaoka K; Tamaoka J; Ueta M; Noguchi K; Kishimoto H
Int J Implant Dent; 2017 Dec; 3(1):11. PubMed ID: 28361376
[TBL] [Abstract][Full Text] [Related]
17. Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial.
Sim IW; Borromeo GL; Tsao C; Hardiman R; Hofman MS; Papatziamos Hjelle C; Siddique M; Cook GJR; Seymour JF; Ebeling PR
J Clin Oncol; 2020 Sep; 38(26):2971-2980. PubMed ID: 32614699
[TBL] [Abstract][Full Text] [Related]
18. The role, efficacy and outcome measures for teriparatide use in the management of medication-related osteonecrosis of the jaw.
Anabtawi M; Tweedale H; Mahmood H
Int J Oral Maxillofac Surg; 2021 Apr; 50(4):501-510. PubMed ID: 32800674
[TBL] [Abstract][Full Text] [Related]
19. Effects of daily versus weekly teriparatide for medication-related osteonecrosis of the jaw: A case-control study.
Kim KM; Kim S; Hwang H; Kim HY; Kim D; Park JH; Choo H; Kim JW
Oral Dis; 2023 Nov; ():. PubMed ID: 37927178
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes of adjunctive teriparatide therapy for medication-related osteonecrosis of the jaw (MRONJ): A multicenter retrospective analysis in Japan.
Morishita K; Yamada SI; Kawakita A; Hashidume M; Tachibana A; Takeuchi N; Ohbayashi Y; Kanno T; Yoshiga D; Narai T; Sasaki N; Shinohara H; Uzawa N; Miyake M; Tominaga K; Kodani I; Umeda M; Kurita H
J Orthop Sci; 2020 Nov; 25(6):1079-1083. PubMed ID: 32111549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
